GlyCardial Diagnostics has completed patient recruitment in EDICA trial: a multicenter international clinical study for the early detection of Myocardial Ischaemia.
Author: admin
Post
GlyCardial Diagnostics has been granted with a Digital Sandbox Programme Project
GlyCardial Diagnostics has been granted with a Digital Sandbox Programme Project
Post
Judit Cubedo has been selected as finalist for the EU Prize for Women Innovators 2020
We are honoured to announce that our CEO Judit Cubedo has been selected as finalist for the EU Prize for Women Innovators 2020!
Post
Prof. Juan Carlos Kaski as Chief Medical Officer of GlyCardial Diagnostics
GlyCardial Diagnostics incorporates Prof. Juan Carlos Kaski as Chief Medical Officer to oversee the Clinical Development.
Post
GlyCardial Diagnostics enrols the first patient in EDICA trial
GlyCardial Diagnostics starts the enrolment of patients in EDICA trial: a multicenter international clinical study for the early detection of Myocardial Ischaemia.
Post
“From the lab to a success story”. GlyCardial Diagnostics’ full-page article in La Vanguardia
“From the lab to a success story” / “Del laboratorio a un caso de éxito”. GlyCardial Diagnostics has been presented in one of the most famous Spanish newspapers (La Vanguardia).
Post
GlyCardial Diagnostics has been granted with regional and sectorial Emprendedor XXI prize
GlyCardial Diagnostics has been awarded the prestigious “Emprendedor XXI Prize” in Catalunya and the sectorial “Emprendedor XXI - HealthTech” from DayOne - CaixaBank.
Post
Dr. Calatzis appointed as non-executive Chairman of the Board of Directors
GlyCardial Diagnostics incorporates Dr. Andreas Calatzis as non-executive Chairman of the Board of Directors.
Post
GlyCardial Diagnostics at the EIT Health annual meeting 2018
GlyCardial Diagnostics attended the EIT Health annual meeting at IESE Business School together with EIT health partners and entrepreneurs.
Post
GlyCardial Diagnostics receives funds from the H2020 Programme
GlyCardial Diagnostics receives 1.9M€ from the SME Instrument Phase II H2020 Programme to advance in the development of the novel test for the early detection of cardiac ischemia.
- 1
- 2